109 related articles for article (PubMed ID: 1348980)
1. Distribution and quantification of somatostatin in inflammatory disease.
Watanabe T; Kubota Y; Sawada T; Muto T
Dis Colon Rectum; 1992 May; 35(5):488-94. PubMed ID: 1348980
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin in the idiopathic inflammatory bowel diseases.
Koch TR; Carney JA; Morris VA; Go VL
Dis Colon Rectum; 1988 Mar; 31(3):198-203. PubMed ID: 2894935
[TBL] [Abstract][Full Text] [Related]
3. The neurochemical changes in the innervation of human colonic mesenteric and submucosal blood vessels in ulcerative colitis and Crohn's disease.
de Fontgalland D; Brookes SJ; Gibbins I; Sia TC; Wattchow DA
Neurogastroenterol Motil; 2014 May; 26(5):731-44. PubMed ID: 24597665
[TBL] [Abstract][Full Text] [Related]
4. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
5. Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitis.
ter Beek WP; Muller ES; Van Hogezand RA; Biemond I; Lamers CB
J Clin Pathol; 2004 Oct; 57(10):1047-51. PubMed ID: 15452158
[TBL] [Abstract][Full Text] [Related]
6. Expression of protooncogene-encoded mRNA by colonic epithelial cells in inflammatory bowel disease.
Alexander RJ; Panja A; Kaplan-Liss E; Mayer L; Raicht RF
Dig Dis Sci; 1996 Apr; 41(4):660-9. PubMed ID: 8674385
[TBL] [Abstract][Full Text] [Related]
7. Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease.
Miklavcic JJ; Hart TD; Lees GM; Shoemaker GK; Schnabl KL; Larsen BM; Bathe OF; Thomson AB; Mazurak VC; Clandinin MT
World J Gastroenterol; 2015 Sep; 21(35):10080-90. PubMed ID: 26401073
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Assessment of CD30+ Lymphocytes in the Intestinal Mucosa Facilitates Diagnosis of Pediatric Ulcerative Colitis.
Fabian O; Hradsky O; Drskova T; Mikus F; Zamecnik J; Bronsky J
Dig Dis Sci; 2018 Jul; 63(7):1811-1818. PubMed ID: 29541900
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
[TBL] [Abstract][Full Text] [Related]
10. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
[TBL] [Abstract][Full Text] [Related]
11. Comparing the type and severity of inflammatory bowel disease in relation to IgG4 immunohistochemical staining.
Şimşek HD; Basyigit S; Aktas B; Vargol E; Şimşek GG; Küçükazman M; Nazlıgül Y
Acta Gastroenterol Belg; 2016; 79(2):216-21. PubMed ID: 27382941
[TBL] [Abstract][Full Text] [Related]
12. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
[TBL] [Abstract][Full Text] [Related]
13. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
14. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
[TBL] [Abstract][Full Text] [Related]
15. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
Klebl FH; Olsen JE; Jain S; Doe WF
J Pathol; 2001 Dec; 195(5):609-15. PubMed ID: 11745698
[TBL] [Abstract][Full Text] [Related]
16.
Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
[TBL] [Abstract][Full Text] [Related]
17. Expression and localization of pannexin-1 hemichannels in human colon in health and disease.
Diezmos EF; Sandow SL; Markus I; Shevy Perera D; Lubowski DZ; King DW; Bertrand PP; Liu L
Neurogastroenterol Motil; 2013 Jun; 25(6):e395-405. PubMed ID: 23594276
[TBL] [Abstract][Full Text] [Related]
18. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
19. Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease.
Weidlich S; Bulau AM; Schwerd T; Althans J; Kappler R; Koletzko S; Mayr D; Bufler P
J Pediatr Gastroenterol Nutr; 2014 Aug; 59(2):e18-26. PubMed ID: 24732025
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease.
Mazumdar S; Das KM
Am J Gastroenterol; 1992 Feb; 87(2):176-81. PubMed ID: 1370872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
